Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Vital Directions for Health and Health Care: Priorities From a National Academy of Medicine Initiative.

Dzau VJ, McClellan MB, McGinnis JM, Burke SP, Coye MJ, Diaz A, Daschle TA, Frist WH, Gaines M, Hamburg MA, Henney JE, Kumanyika S, Leavitt MO, Parker RM, Sandy LG, Schaeffer LD, Steele GD Jr, Thompson P, Zerhouni E.

JAMA. 2017 Apr 11;317(14):1461-1470. doi: 10.1001/jama.2017.1964.

PMID:
28324029
2.

Margaret A. Hamburg, MD, Reflects on 6 Years at FDA.

Hamburg MA, Rubin R.

JAMA. 2015 Jun 16;313(23):2309-10. doi: 10.1001/jama.2015.3911. No abstract available.

PMID:
26080325
3.

Remarks at the Annual Conference of the Food and Drug Law Institute.

Hamburg MA.

Food Drug Law J. 2014;69(3):343-9. No abstract available.

PMID:
27382853
4.

First FDA authorization for next-generation sequencer.

Collins FS, Hamburg MA.

N Engl J Med. 2013 Dec 19;369(25):2369-71. doi: 10.1056/NEJMp1314561. Epub 2013 Nov 19. No abstract available.

5.

Remarks at the annual conference of the Food and Drug Law Institute.

Hamburg MA.

Food Drug Law J. 2013;68(2):217-23. No abstract available.

PMID:
24640470
6.

Creating a space for innovative device development.

McMurry-Heath M, Hamburg MA.

Sci Transl Med. 2012 Dec 5;4(163):163fs43. doi: 10.1126/scitranslmed.3005269. Epub 2012 Dec 3.

PMID:
23209277
7.

Advancing the science of medicines regulation: the role of the 21st-century medicines regulator.

Lumpkin MM, Eichler HG, Breckenridge A, Hamburg MA, Lönngren T, Woods K.

Clin Pharmacol Ther. 2012 Oct;92(4):486-93. doi: 10.1038/clpt.2012.146. Epub 2012 Sep 5. Review.

PMID:
22948890
8.

Science and regulation. FDA's approach to regulation of products of nanotechnology.

Hamburg MA.

Science. 2012 Apr 20;336(6079):299-300. doi: 10.1126/science.1205441. No abstract available.

PMID:
22517845
9.

Advancing global health through regulatory science research: summary of the Global Summit on Regulatory Science Research and Innovation.

Slikker W Jr, Miller MA, Lou Valdez M, Hamburg MA.

Regul Toxicol Pharmacol. 2012 Apr;62(3):471-3. doi: 10.1016/j.yrtph.2012.02.001. Epub 2012 Feb 7.

PMID:
22342950
10.

Remarks at the Annual Conference of the Food and Drug Law Institute.

Hamburg MA.

Food Drug Law J. 2012;67(2):123-9. No abstract available.

PMID:
24620415
11.

The growing role of epidemiology in drug safety regulation.

Hamburg MA.

Epidemiology. 2011 Sep;22(5):622-4. doi: 10.1097/EDE.0b013e31822837ba. No abstract available.

PMID:
21811108
12.

Advancing regulatory science.

Hamburg MA.

Science. 2011 Feb 25;331(6020):987. doi: 10.1126/science.1204432. No abstract available.

13.

Shattuck lecture. Innovation, regulation, and the FDA.

Hamburg MA.

N Engl J Med. 2010 Dec 2;363(23):2228-32. doi: 10.1056/NEJMsa1007467. No abstract available.

14.

The path to personalized medicine.

Hamburg MA, Collins FS.

N Engl J Med. 2010 Jul 22;363(4):301-4. doi: 10.1056/NEJMp1006304. Epub 2010 Jun 15. No abstract available. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092.

15.

The FDA as a public health agency.

Hamburg MA, Sharfstein JM.

N Engl J Med. 2009 Jun 11;360(24):2493-5. doi: 10.1056/NEJMp0903764. Epub 2009 May 26. No abstract available.

16.

SARS and its implications for U.S. public health policy: "we've been lucky".

Hearne SA, Hamburg MA, Segal L.

Biosecur Bioterror. 2004;2(2):127-31. Review. No abstract available.

PMID:
15225407
17.

Bioterrorism: responding to an emerging threat.

Hamburg MA.

Trends Biotechnol. 2002 Jul;20(7):296-8.

PMID:
12062974
18.

Challenges confronting public health agencies.

Hamburg MA.

Public Health Rep. 2001;116 Suppl 2:59-63. No abstract available.

19.

Public health preparedness.

Hamburg MA.

Science. 2002 Feb 22;295(5559):1425. No abstract available.

20.

National perspective: United States.

Hamburg MA.

Womens Health Issues. 2001 Jul-Aug;11(4):282-92. No abstract available.

PMID:
11479074
21.

Bioterrorism: a challenge to public health and medicine.

Hamburg MA.

J Public Health Manag Pract. 2000 Jul;6(4):38-44. Review.

PMID:
10977611
22.

Addressing bioterrorist threats: where do we go from here?

Hamburg MA.

Emerg Infect Dis. 1999 Jul-Aug;5(4):564-5. No abstract available.

23.

Declining HIV/AIDS mortality in New York City.

Chiasson MA, Berenson L, Li W, Schwartz S, Singh T, Forlenza S, Mojica BA, Hamburg MA.

J Acquir Immune Defic Syndr. 1999 May 1;21(1):59-64.

PMID:
10235515
24.

Public health and urban medicine.

Hamburg MA.

Lancet. 1996 Oct 12;348(9033):1008-10. No abstract available.

PMID:
8855866
25.

Tuberculosis in New York City--turning the tide.

Frieden TR, Fujiwara PI, Washko RM, Hamburg MA.

N Engl J Med. 1995 Jul 27;333(4):229-33.

26.

Fusing excellence to reform.

Hamburg MA.

Ann N Y Acad Sci. 1994 Nov 4;729:1-7. No abstract available.

PMID:
7998720
27.

Tuberculosis clinics.

Frieden TR, Fujiwara PI, Hamburg MA, Ruggiero D, Henning KJ.

Am J Respir Crit Care Med. 1994 Oct;150(4):893-4. No abstract available.

PMID:
7921458
28.

Tuberculosis transmission in the 1990s.

Hamburg MA, Frieden TR.

N Engl J Med. 1994 Jun 16;330(24):1750-1. No abstract available.

PMID:
7910663
29.

Urgent issues in public health.

Hamburg MA.

Bull N Y Acad Med. 1993 Jan-Feb;69(1):14-22. No abstract available.

30.

Rebuilding the public health infrastructure: the challenge of tuberculosis control in New York City.

Hamburg MA.

J Law Med Ethics. 1993 Fall-Winter;21(3-4):352-9. No abstract available.

PMID:
8167810
31.

The challenge of controlling tuberculosis in New York City.

Hamburg MA.

N Y State J Med. 1992 Jul;92(7):291-3. No abstract available.

PMID:
1518584
32.

The AIDS research agenda at the National Institutes of Health.

Minor JR, Hamburg MA.

Am J Hosp Pharm. 1991 Dec;48(12):2662-6.

PMID:
1667566
33.
34.

Opportunities for health promotion and disease prevention in the clinical setting.

McGinnis JM, Hamburg MA.

West J Med. 1988 Oct;149(4):468-74. Review.

35.

Electrophysiological and receptor studies in rat brain: effects of clorgyline.

Campbell IC, Gallager DW, Hamburg MA, Tallman JF, Murphy DL.

Eur J Pharmacol. 1985 May 20;111(3):355-64.

PMID:
2990957

Supplemental Content

Loading ...
Support Center